Acorda Therapeutics Overview

Acorda Therapeutics Other Income Expense Net

Other Income/Expense Net for ACOR.

Quarterly Other Income/Expense

-$5.67M

↑ 10.01% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

-$256.58M

↓ 4199.46% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin